Directly to content
  1. Publishing |
  2. Search |
  3. Browse |
  4. Recent items rss |
  5. Open Access |
  6. Jur. Issues |
  7. DeutschClear Cookie - decide language by browser settings

The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression

Gündogdu, Mehtap S. ; Liu, He ; Metzdorf, Daniela ; Hildebrand, Dagmar ; Aigner, Michael ; Aktories, Klaus ; Heeg, Klaus ; Kubatzky, Katharina F.

In: Molecular cancer, 9 (2010), Nr. 225. pp. 1-13. ISSN 1476-4598

[img]
Preview
PDF, English
Download (1MB) | Lizenz: Creative Commons LizenzvertragThe haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression by Gündogdu, Mehtap S. ; Liu, He ; Metzdorf, Daniela ; Hildebrand, Dagmar ; Aigner, Michael ; Aktories, Klaus ; Heeg, Klaus ; Kubatzky, Katharina F. underlies the terms of Creative Commons Attribution 3.0 Germany

Citation of documents: Please do not cite the URL that is displayed in your browser location input, instead use the DOI, URN or the persistent URL below, as we can guarantee their long-time accessibility.

Abstract

Background: RhoH is a constitutively active member of the family of Rho GTPases. Its expression is restricted to the haematopoietic lineage, where it serves as a positive regulator for T cell selection and mast cell function and as a negative regulator for growth-related functions in other lineages. Here, we examined the activation of signal transducer and activator of transcription (STAT) proteins in response to stimulation with interleukin 3 (IL3). Results: Using the murine IL3-dependent cell line BaF3 we investigated the influence of RhoH protein expression levels on IL3-mediated cellular responses. RhoH overexpressing cells showed lower sensitivity to IL3 and decreased STAT5 activation. SiRNA-mediated repression of RhoH gene expression led to an increase in proliferation and STAT5 activity which correlated with an increased number of IL3 receptor α chain molecules, also known as CD123, expressed at the cell surface. Interestingly, these findings could be reproduced using human THP-1 cells as a model system for acute myeloid leukaemia, where low RhoH levels are known to be an unfavourable prognostic marker. Overexpression of RhoH on the other hand caused an induction of STAT1 activity and western blot analysis revealed that activated STAT1 is phosphorylated on Tyr701. STAT1 is known to induce apoptosis or cell cycle arrest and we detected an upregulation of cyclin-dependent kinase inhibitors (CDKI) p21 Cip1 and p27 Kip1 in RhoH overexpressing BaF3 cells. Conclusions: We propose that RhoH functions as a negative regulator for IL3-induced signals through modulation of the JAK-STAT pathway. High levels of RhoH allow the IL3-dependent activation of STAT1 causing decreased proliferation through upregulation of p21 Cip1 and p27 Kip1. Low RhoH levels on the other hand led to an upregulation of IL3-dependent cell growth, STAT5 activity and an increase of CD123 surface expression, linking RhoH to a CD123/STAT5 phenotype that has been described in AML patients.

Item Type: Article
Journal or Publication Title: Molecular cancer
Volume: 9
Number: 225
Publisher: Biomed Central
Place of Publication: London
Date Deposited: 27 May 2015 06:36
Date: 2010
ISSN: 1476-4598
Page Range: pp. 1-13
Faculties / Institutes: Medizinische Fakultät Heidelberg > Department for Infectiology
Subjects: 570 Life sciences
610 Medical sciences Medicine
About | FAQ | Contact | Imprint |
OA-LogoDINI certificate 2013Logo der Open-Archives-Initiative